Testing the effects of the BET small-molecule inhibitor JQ1 in a panel of 20 colon cancer cell lines with similar proliferation rates, a subset of six cell lines exquisitely sensitive to JQ1, which were CIMP+ was identified, while the six most resistant cell lines were all CIMP-. This evidence concerns the gene DNER and malignant colon neoplasm.